Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
Jan Krönke(German Cancer Research Center), Konstanze Döhner(University Hospital Ulm), Marie von Lilienfeld‐Toal(St James's University Hospital), Mohammed Wattad(San Antonio College), Kai‐Ole Jensen(Johannes Gutenberg University Mainz), Marianne Habdank(Johannes Gutenberg University Mainz), Helmut R. Salih(San Antonio College), Florian Tschürtz(Johannes Gutenberg University Mainz), Daniela Späth(University Hospital Ulm), Brigitte Schlegelberger(Heidelberg University), Michael Lübbert(University of Freiburg), Karina Eiwen(Johannes Gutenberg University Mainz), Richard F. Schlenk(University Hospital Ulm), David Nachbaur(Innsbruck Medical University), Shiva Onken(Johannes Gutenberg University Mainz), Gudrun Göhring(Medizinische Hochschule Hannover), Peter Paschka(European Bioinformatics Institute), Verena I. Gaidzik(European Bioinformatics Institute), Hartmut Döhner(Universität Ulm), Detlef Haase(University of Göttingen), Andrea Corbacioglu(Düsseldorf University Hospital), H.‐G. Mergenthaler(Johannes Gutenberg University Mainz), Gerhard Held(Saarland University), Jürgen Krauter(Goethe University Frankfurt), Thomas Kindler(University of Applied Sciences Mainz), Ulrich Germing(Johannes Gutenberg University Mainz), Arnold Ganser(Goethe University Frankfurt)
Cited by 393
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k